Search

everythinglearnresearchcommunity

for

Search:↓

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Drugs can change hair growth and this is important because it can upset people.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Manipulating cell cleanup processes could help treat hair loss.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Treatments for hair loss vary, but cell-based options may be the future.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Gender identity can be more diverse than just male or female.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

Yes, smoking damages your skin.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

The document listed medical job ads and guidelines for breast cancer screening.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.